Variant Synonymizer: Platform to identify mutations defined in different ways is available now!

VarSy

Over 2,000 gene–disease validation summaries are now available—no login required!

Browse Summaries

RFC1 – Cerebellar Ataxia with Neuropathy and Vestibular Areflexia Syndrome

Cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS) is an adult-onset autosomal recessive neurodegenerative disorder caused by biallelic pentanucleotide intronic expansions in RFC1 and, more recently, by compound heterozygosity with loss-of-function sequence variants (PMID:35306791). CANVAS manifests with progressive cerebellar ataxia (HP:0001251), cerebellar atrophy (HP:0001272), sensory neuronopathy, and bilateral vestibular areflexia.

In a cohort of 15 CANVAS patients carrying a single (AAGGG)n expansion, whole-genome or exome sequencing identified seven affected individuals from five unrelated families harboring a second truncating RFC1 variant in trans (e.g., c.1267C>T (p.Arg423Ter), c.1739_1740del (p.Lys580SerfsTer9), c.2191del (p.Gly731GlufsTer6), c.2876del (p.Pro959GlnfsTer24)) with confirmed segregation (PMID:36289003).

A representative novel variant, c.1147C>T (p.Arg383Ter), was identified in trans with a pathogenic intronic expansion in an adult proband; long-read sequencing confirmed allelic phase and patient RNA studies demonstrated complete absence of transcript from the nonsense allele, consistent with nonsense-mediated decay (PMID:36524104).

Genetic evidence: autosomal recessive inheritance with compound heterozygous expansions and LoF variants in at least eight unrelated probands across six families supports a Strong gene–disease association.

Functional assays in patient-derived cells for c.1147C>T, c.1267C>T, and c.2876del variants demonstrated reduced RFC1 transcript and protein levels, confirming loss-of-function as the pathogenic mechanism (PMID:36289003; PMID:36524104).

No studies have refuted this association. Additional reports of biallelic RFC1 mutations in patients with immune-mediated neuropathies indicate an expanded phenotypic spectrum (PMID:37853169).

Key Take-home: RFC1 should be included in genetic testing panels for adult-onset cerebellar ataxia and sensory neuropathy to detect both intronic expansions and coding loss-of-function variants.

References

  • Journal of movement disorders • 2022 • Expanding the Clinical Spectrum of RFC1 Gene Mutations. PMID:35306791
  • Neurology Genetics • 2022 • Whole-Genome and Long-Read Sequencing Identify a Novel Mechanism in RFC1 Resulting in CANVAS Syndrome. PMID:36524104
  • Neurology • 2023 • Truncating Variants in RFC1 in Cerebellar Ataxia, Neuropathy, and Vestibular Areflexia Syndrome. PMID:36289003
  • Scientific reports • 2023 • CANVAS-related RFC1 mutations in patients with immune-mediated neuropathy. PMID:37853169

Evidence Based Scoring (AI generated)

Gene–Disease Association

Strong

Eight unrelated probands with biallelic pathogenic RFC1 variants from six families, segregation in five families, concordant functional data

Genetic Evidence

Strong

Compound heterozygous intronic expansions and loss-of-function variants identified in eight probands; reached genetic evidence cap

Functional Evidence

Moderate

Patient cell assays show nonsense-mediated decay and reduced transcript/protein for multiple truncating variants consistent with loss-of-function